Short communicationPublished 30 Oct 2023
Clinical Perspectives and Innovative Treatment Approaches for E. coli Urinary Tract Infections
Department of Medical Microbiolohy, Radboud University Medical Center, Netherlands
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) are a pervasive global health issue, presenting clinical challenges due to antibiotic resistance. This article explores clinical perspectives on E. coli UTIs and innovative treatment approaches. Traditional antibiotics, once effective, are facing increasing resistance. Innovative solutions, including fosfomycin, phage therapy, vaccines, probiotics, CRISPR-based therapies, and nanotechnology, offer potential breakthroughs. A patient-centered approach, coupled with prevention strategies, is essential in E. coli UTI management. These innovative treatments represent promising advancements in the field, highlighting the potential for more effective solutions to combat E. coli UTIs.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Disease and Pathology
- SubjectInfectious Diseases
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Veerdonk Garbino”